Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Katoh

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 17, 2022
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2Ayaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2011
Changes in expression of drug-metabolizing enzymes by single-walled carbon nanotubes in human respiratory tract cellsKotaro Hitoshi, Miki Katoh, Tomoko Suzuki, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Drug Metabolism and Pharmacokinetics|January 5, 2010
Inhibitory effects of Kampo medicine on human UGT2B7 activityNao Nakagawa, Miki Katoh, Yuko Yoshioka, et al.
Biological & Pharmaceutical Bulletin|September 5, 2017
Characterization of β-Estradiol 3-Glucuronidation in Rat BrainYuki Asai, Yukiko Sakakibara, Haruka Onouchi, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 17, 2022
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2Ayaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 2007
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substratesRyoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2007
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactionsMiki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2006
CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 22, 2011
Changes in expression of drug-metabolizing enzymes by single-walled carbon nanotubes in human respiratory tract cellsKotaro Hitoshi, Miki Katoh, Tomoko Suzuki, et al.
Chemical Research in Toxicology|February 13, 2008
Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and tolueneTatsuki Fukami, Miki Katoh, Hiroshi Yamazaki, et al.
Drug Metabolism and Pharmacokinetics|January 5, 2010
Inhibitory effects of Kampo medicine on human UGT2B7 activityNao Nakagawa, Miki Katoh, Yuko Yoshioka, et al.
Biological & Pharmaceutical Bulletin|September 5, 2017
Characterization of β-Estradiol 3-Glucuronidation in Rat BrainYuki Asai, Yukiko Sakakibara, Haruka Onouchi, et al.
Pageof 8